查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1412721

子宫内避孕器市场：按类型、年龄层、最终用户划分 - 全球预测 2024-2030

Intrauterine Devices Market by Type (Hormonal: Progestogen-releasing IUD, Nonhormonal: Copper-containing IUD), Age Group (15-24 Years, 25-34 Years, 35-44 Years), End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

子宫内避孕器市场规模预计2023年为31.3亿美元，2024年达32.4亿美元，预计2030年将达42.9亿美元，复合年增长率为4.59%。

全球子宫内避孕器市场

主要市场统计
基准年[2023] 31.3亿美元
预测年份 [2024] 32.4亿美元
预测年份 [2030] 42.9亿美元
复合年增长率（%） 4.59%
子宫内避孕器市场-IMG1

FPNV定位矩阵

FPNV定位矩阵对于评估子宫内避孕器市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出资讯的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对子宫内避孕器市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵考察，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更资讯的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场，并分析它们在成熟细分市场中的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1-子宫内避孕器市场的市场规模和预测是多少？

2-在子宫内避孕器市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些？

3-子宫内避孕器市场的技术趋势和法律规范是什么？

4-子宫内避孕器市场主要供应商的市场占有率是多少？

5-进入子宫内避孕器市场的合适型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 增加收养以避免意外怀孕
      • 政府和非政府组织努力推广子宫内避孕器
    • 抑制因素
      • 担心丢失绳子和使用子宫内避孕器带来的感染风险
    • 机会
      • 专注于设计下一代IUD（子宫内避孕器）
      • 推出智慧子宫内避孕器
    • 任务
      • 大众的认识和采纳有限
  • 市场区隔分析
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第六章子宫内避孕器市场：依类型

  • 荷尔蒙：释放黄体素的子宫内避孕器
  • 非荷尔蒙：含铜子宫内避孕器

第七章子宫内避孕器市场：依年龄组别

  • 15-24岁
  • 25-34岁
  • 35-44岁
  • 44岁以上

第八章子宫内避孕器市场：依最终用户分类

  • 诊所
  • 社区医疗中心
  • 医院

第九章 北美和南美子宫内避孕器市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太子宫内避孕器市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲子宫内避孕器市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：主要企业
  • 主要企业竞争情境分析

第13章竞争产品组合

  • 主要公司简介
    • Actavis Generics by Teva Pharmaceutical Industries Ltd.
    • Agile Therapeutics, Inc.
    • Allergan Plc by Abbvie Inc
    • Ava AG
    • Bayer AG
    • Cardinal Health, Inc.
    • Contrel Europe NV
    • CooperSurgical Inc.
    • Egemen International
    • ERENLER MEDIKAL SAN. TIC. LTD. STI.
    • Eurogine SL
    • Fuji Latex Co., Ltd.
    • HLL Lifecare Limited
    • HRA Pharma, SAS
    • Melbea AG
    • Merck & Co., Inc.
    • Meril Life Sciences Pvt. Ltd.
    • Mona Lisa NV
    • Mylan NV by Viatris Inc.
    • Novartis AG
    • Ocon Medical Ltd
    • Pregna International Limited
    • Prosan International BV
    • Searchlight Pharma Inc.
    • SMB Corporation of India
  • 主要产品系列

第十四章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-8E22B61932D7

[185 Pages Report] The Intrauterine Devices Market size was estimated at USD 3.13 billion in 2023 and expected to reach USD 3.24 billion in 2024, at a CAGR 4.59% to reach USD 4.29 billion by 2030.

Global Intrauterine Devices Market

KEY MARKET STATISTICS
Base Year [2023] USD 3.13 billion
Estimated Year [2024] USD 3.24 billion
Forecast Year [2030] USD 4.29 billion
CAGR (%) 4.59%
Intrauterine Devices Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Intrauterine Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Intrauterine Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Intrauterine Devices Market, highlighting leading vendors and their innovative profiles. These include Actavis Generics by Teva Pharmaceutical Industries Ltd., Agile Therapeutics, Inc., Allergan Plc by Abbvie Inc, Ava AG, Bayer AG, Cardinal Health, Inc., Contrel Europe NV, CooperSurgical Inc., Egemen International, ERENLER MEDIKAL SAN. TIC. LTD. STI., Eurogine S.L., Fuji Latex Co., Ltd., HLL Lifecare Limited, HRA Pharma, SAS, Melbea AG, Merck & Co., Inc., Meril Life Sciences Pvt. Ltd., Mona Lisa N.V., Mylan NV by Viatris Inc., Novartis AG, Ocon Medical Ltd, Pregna International Limited, Prosan International BV, Searchlight Pharma Inc., and SMB Corporation of India.

Market Segmentation & Coverage

This research report categorizes the Intrauterine Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Hormonal: Progestogen-releasing IUD
    • Nonhormonal: Copper-containing IUD
  • Age Group
    • 15-24 Years
    • 25-34 Years
    • 35-44 Years
    • Above 44 Years
  • End User
    • Clinics
    • Community Health Care Centres
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Intrauterine Devices Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Intrauterine Devices Market?

3. What are the technology trends and regulatory frameworks in the Intrauterine Devices Market?

4. What is the market share of the leading vendors in the Intrauterine Devices Market?

5. Which modes and strategic moves are suitable for entering the Intrauterine Devices Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Intrauterine Devices Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising adoption to avoid unintended pregnancies
      • 5.1.1.2. Government and NGO initiatives to promote IUD
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns related to lost strings and risk of infection due to IUD usage
    • 5.1.3. Opportunities
      • 5.1.3.1. Focus on the design of next-generation IUD (intrauterine device)
      • 5.1.3.2. Emergence of smart intrauterine contraceptive device
    • 5.1.4. Challenges
      • 5.1.4.1. Limited awareness and adoption among population
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Intrauterine Devices Market, by Type

  • 6.1. Introduction
  • 6.2. Hormonal: Progestogen-releasing IUD
  • 6.3. Nonhormonal: Copper-containing IUD

7. Intrauterine Devices Market, by Age Group

  • 7.1. Introduction
  • 7.2. 15-24 Years
  • 7.3. 25-34 Years
  • 7.4. 35-44 Years
  • 7.5. Above 44 Years

8. Intrauterine Devices Market, by End User

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Community Health Care Centres
  • 8.4. Hospitals

9. Americas Intrauterine Devices Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Intrauterine Devices Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Intrauterine Devices Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Actavis Generics by Teva Pharmaceutical Industries Ltd.
    • 13.1.2. Agile Therapeutics, Inc.
    • 13.1.3. Allergan Plc by Abbvie Inc
    • 13.1.4. Ava AG
    • 13.1.5. Bayer AG
    • 13.1.6. Cardinal Health, Inc.
    • 13.1.7. Contrel Europe NV
    • 13.1.8. CooperSurgical Inc.
    • 13.1.9. Egemen International
    • 13.1.10. ERENLER MEDIKAL SAN. TIC. LTD. STI.
    • 13.1.11. Eurogine S.L.
    • 13.1.12. Fuji Latex Co., Ltd.
    • 13.1.13. HLL Lifecare Limited
    • 13.1.14. HRA Pharma, SAS
    • 13.1.15. Melbea AG
    • 13.1.16. Merck & Co., Inc.
    • 13.1.17. Meril Life Sciences Pvt. Ltd.
    • 13.1.18. Mona Lisa N.V.
    • 13.1.19. Mylan NV by Viatris Inc.
    • 13.1.20. Novartis AG
    • 13.1.21. Ocon Medical Ltd
    • 13.1.22. Pregna International Limited
    • 13.1.23. Prosan International BV
    • 13.1.24. Searchlight Pharma Inc.
    • 13.1.25. SMB Corporation of India
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. INTRAUTERINE DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. INTRAUTERINE DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. INTRAUTERINE DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. INTRAUTERINE DEVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. INTRAUTERINE DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. INTRAUTERINE DEVICES MARKET DYNAMICS
  • FIGURE 7. INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 10. INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 12. INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES INTRAUTERINE DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES INTRAUTERINE DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. INTRAUTERINE DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. INTRAUTERINE DEVICES MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. INTRAUTERINE DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. INTRAUTERINE DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INTRAUTERINE DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. INTRAUTERINE DEVICES MARKET SIZE, BY HORMONAL: PROGESTOGEN-RELEASING IUD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. INTRAUTERINE DEVICES MARKET SIZE, BY NONHORMONAL: COPPER-CONTAINING IUD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 9. INTRAUTERINE DEVICES MARKET SIZE, BY 15-24 YEARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. INTRAUTERINE DEVICES MARKET SIZE, BY 25-34 YEARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. INTRAUTERINE DEVICES MARKET SIZE, BY 35-44 YEARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. INTRAUTERINE DEVICES MARKET SIZE, BY ABOVE 44 YEARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 14. INTRAUTERINE DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. INTRAUTERINE DEVICES MARKET SIZE, BY COMMUNITY HEALTH CARE CENTRES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. INTRAUTERINE DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES INTRAUTERINE DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM INTRAUTERINE DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM INTRAUTERINE DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM INTRAUTERINE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. INTRAUTERINE DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 145. INTRAUTERINE DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. INTRAUTERINE DEVICES MARKET LICENSE & PRICING